TBScience registration is closed, participants cannot register for this pre-conference on the day
Back to top
Conference News

The Lancet profiles the winner of the Stephen Lawn TB-HIV Research Leadership Prize

28 Mar 2018

Dr Leo Martinez, as part of winning the inaugural The Stephen Lawn TB-HIV Research Leadership Prize, has been profiled in The Lancet this week – highlighting his outstanding research on reducing the childhood tuberculosis (TB) burden.

Dr Martinez is a postdoctoral research fellow at Stanford University’s School of Medicine. He received his PhD in Epidemiology from the University of Georgia in 2017 and his Masters of Public Health from Tulane University School of Public Health and Tropical Medicine in 2012.

His research, conducted primarily in Uganda, has a focus on childhood TB and covers a range of interests including the epidemiology of tuberculosis with a focus on the location of occurrence for person-to-person transmission; and also applying meaningful, effective interventions and policy recommendations to mitigate the spread of TB in economically impoverished settings.

Speaking in The Lancet, Jason Andrews, Assistant Professor of Medicine (Infectious Diseases) at Stanford University said: “Leo has demonstrated how to efficiently identify TB cases among children through targeted household contact investigations in settings with limited resources.”

The Stephen Lawn Memorial Fund was established in 2016 through a global partnership between the TB Centre of the London School of Hygiene and Tropical Medicine (UK), the Desmond Tutu HIV Centre, at the University of Cape Town, South Africa and The Union, also supported by The Lancet. The Research Leadership Prize, as part of the Fund, is for innovative research on tuberculosis and HIV in sub-Saharan Africa and acknowledges young researchers conducting promising work focused on reducing the disease burden of TB and HIV/AIDS in Africa.


Follow Us

As countries transition from @GlobalFund funding to domestic resources for TB, HIV and malaria - are they prepared… https://t.co/DQ2VH4EYBb

MSF will be at The 49th Union World Conference on Lung Health @UnionConference. Check out our events:… https://t.co/K4e1TK4aGI

Only half the people who start #MDRTB treatment are cured. Unitaid is investing $81 million to improve treatment re… https://t.co/LTgNLQQREP

Receive Conference News & Updates